epirubicin has been researched along with Infection in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
| Bergmann, M; Busch, R; Emmerich, B; Franke, A; Hallek, M; Hiddemann, W; Hopfinger, G; Pasold, R; Schlag, R; Schmitt, B; Wendtner, CM | 1 |
| Avilés, A; Castañeda, C; Cleto, S; González, M; Huerta-Guzmán, J; Neri, N; Talavera, A | 1 |
| Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G | 1 |
| Chevallier, B; Chollet, P; Fargeot, P; Fizames, C; Fumoleau, P; Genot, JY; Kerbrat, P; Merrouche, Y; Olivier, JP; Roche, H | 1 |
| Chevallier, B; Chollet, P; Hurteloup, P; Olivier, JP; Roche, H | 1 |
| Badellino, F; Canavese, G; Catturich, A; Gipponi, M; Repetto, L; Sertoli, MR; Tomei, D; Vecchio, C | 1 |
1 review(s) available for epirubicin and Infection
| Article | Year |
|---|---|
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chlorambucil; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2002 |
6 trial(s) available for epirubicin and Infection
| Article | Year |
|---|---|
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy.
Topics: Actuarial Analysis; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Infections; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vinblastine | 2003 |
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine | 2008 |
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Middle Aged; Neutropenia; Pharmaceutical Vehicles; Recombinant Proteins; Thrombocytopenia | 1995 |
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Ethinyl Estradiol; Female; Fever; Fluorouracil; Hematologic Diseases; Humans; Infections; Length of Stay; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Neoplasm Staging; Pilot Projects; Remission Induction | 1993 |
Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bandages; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drainage; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infections; Length of Stay; Lymph; Methotrexate; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome; Wound Healing | 1997 |